Laura González-Fajardo

Ex Vivo Host and Parasite Response to Antileishmanial Drugs and Immunomodulators

N. Saravia, D. Mcmahon-Pratt, O. Fernández, 2015, PLoS neglected tropical diseases.

Tumor-mesoporous silica nanoparticle interactions following intraperitoneal delivery for targeting peritoneal metastasis.

A. Salner, Laura González-Fajardo, M. Jay, 2020, Journal of controlled release : official journal of the Controlled Release Society.

Influence of the Method of Preparation on the Characteristics and Performance of Cholesterol-based Polymeric Nanoparticles for Redox-triggered Release of Doxorubicin in Tumor Cells.

R. Kasi, Laura González-Fajardo, Xiuling Lu, 2019, International journal of pharmaceutics.

Engineering Multifunctional Gold Decorated Dendritic Mesoporous Silica/Tantalum Oxide Nanoparticles for Intraperitoneal Tumor‐Specific Delivery

D. Munteanu, B. Ahmadi, S. Shahbazmohamadi, 2019, Particle & Particle Systems Characterization.

Redox Potential and ROS-Mediated Nanomedicines for Improving Cancer Therapy.

Laura González-Fajardo, Sterling Glass, Xiuling Lu, 2017, Antioxidants & redox signaling.

Long circulating self-assembled nanoparticles from cholesterol-containing brush-like block copolymers for improved drug delivery to tumors.

R. Kasi, P. Deshmukh, L. Lai, 2014, Biomacromolecules.

Reduced in vivo toxicity of doxorubicin by encapsulation in cholesterol-containing self-assembled nanoparticles.

Ming-Hui Chen, R. Kasi, J. Manautou, 2016, Pharmacological research.

Fluorescent, bioactive protein nanoparticles (prodots) for rapid, improved cellular uptake.

J. Gutkind, C. Kumar, V. Patel, 2015, Bioconjugate chemistry.

Tumor Accumulation and Penetration of Mesoporous Silica Nanoparticles and the Potential Role of Peritoneal Macrophages

M. Brewer, Laura González-Fajardo, Derek Hargrove, 2014 .

Reduced in vivo toxicity of doxorubicin by encapsulation in cholesterol-containing self-assembled nanoparticles.

Ming-Hui Chen, R. Kasi, J. Manautou, 2016, Pharmacological research.